Product NDC: | 0378-6151 |
Proprietary Name: | MENTAX |
Non Proprietary Name: | butenafine hydrochloride |
Active Ingredient(s): | 10 mg/g & nbsp; butenafine hydrochloride |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-6151 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020524 |
Marketing Category: | NDA |
Start Marketing Date: | 19961231 |
Package NDC: | 0378-6151-46 |
Package Description: | 1 TUBE in 1 CARTON (0378-6151-46) > 15 g in 1 TUBE |
NDC Code | 0378-6151-46 |
Proprietary Name | MENTAX |
Package Description | 1 TUBE in 1 CARTON (0378-6151-46) > 15 g in 1 TUBE |
Product NDC | 0378-6151 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | butenafine hydrochloride |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 19961231 |
Marketing Category Name | NDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | BUTENAFINE HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/g |
Pharmaceutical Classes | Benzylamine Antifungal [EPC],Benzylamines [Chemical/Ingredient] |